Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Accelerating Study Start-Up And Patient Recruitment For Clinical Trials
A network of proven and trusted sites means sponsors can progress quickly through the site selection process to study startup and then be assured of reliable patient recruitment and robust data.
Trends In Clinical Trials In 2025: Navigating A Transformative Landscape
In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.
Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems
Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.

Ophthalmology Assessments Made Simple: A Guide For Clinical Trials
1/29/2025

Explore the importance and requirements of ophthalmology assessments as well as the key challenges that complicate their implementation at clinical sites.
Inclusive Trial Design A 'Must-Have' In Modern R&D
8/14/2025

Inclusivity in trial design is a crucial aspect of the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health.
Recruiting & Retaining More Patients Per Site:
3/14/2025

Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
Beyond Go-Live: The True RTSM Quality Test
3/25/2026

Go‑live is only the beginning. This clip highlights how RTSM performance evolves over years of real‑world use — and why long‑term flexibility is just as important as a clean launch.
Reimagining Medical Monitoring In Clinical Research
4/11/2025

Clinical trials are undergoing a transformative shift driven by evolving regulations, advanced technologies, and decentralized methodologies.

A New Blueprint For Transforming Feasibility And Recruitment

Clinical trials often fail due to poor feasibility planning. A new AI-powered approach bridges protocol design with real-world patient access to improve enrollment success.
Making The Impossible Possible In Oncology And Hematology Clinical Development

When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Designed Around Your Needs: Let's Accelerate Enrollment Together

CSSi offers unmatched depth and breadth in therapeutic expertise, providing full-spectrum, in-house capabilities, positing the organization as a true end-to-end partner in clinical trials.
Accelerating Patient Recruitment In Oncology Since 2005

CSSi is a global, full-service company offering customized services to support recruitment and retention programs around the world.